Thermo Fisher Scientific | TMO - Operating Expenses


Thermo Fisher Scientific reported $9.09B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Agilent USD 1.44B 9M Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Henry Schein USD 3.17B 77M Mar/2026
Illumina USD 852M 51M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Laboratory Of America USD 3.13B 6.3M Mar/2026
Medtronic USD 7.72B 436M Mar/2026
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Olympus JPY 268.42B 35.37B Mar/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Repligen USD 174.27M 3.67M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Veracyte USD 119.99M 3.99M Mar/2026
Waters USD 1.12B 457.15M Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026